London, December 2018: Stanhope, Mitsui Fudosan and AIMCo announce today that GammaDelta Therapeutics Ltd is to become the latest life sciences company to take space at White City Place, the 1.9 million square foot business, innovation and life sciences district in West London alongside Imperial College’s White City Campus. White City Place is fast becoming the centre of the emerging life science cluster in West London, with pharmaceutical giant Novartis recently announcing that they are moving their UK headquarters to the site.
GammaDelta Therapeutics will join fellow innovators Autolus and Synthace in White City Place and OpenCell, Rebelbio and Blenheim Chalcot will be their neighbours in the London Borough of Hammersmith & Fulham. White City Place encourages collaboration between its life sciences tenants and amongst the wider life science community, reinforced by the London Borough of Hammersmith and Fulham’s Industrial Strategy.
Moving from the London BioScience Innovation Centre near St Pancras, GammaDelta Therapeutics will be taking approximately 12,000 square feet of office and lab space in the WestWorks building, which it will use as its base to develop immunotherapies for cancer and other serious immune-related diseases. GammaDelta Therapeutics also has a research facility within the Incubator at the Translation and Innovation Hub at Imperial College London. Founded in 2016 by transatlantic bioscience investment firm Abingworth, based on pioneering research conducted at King’s College London and The Francis Crick Institute into gamma delta T cells, GammaDelta Therapeutics is developing improved immunotherapies for a range of malignant diseases.
The announcement of GammaDelta Therapeutics’ relocation follows last year’s news that Japanese pharmaceutical company Takeda Pharmaceutical Company, Ltd and Abingworth committed to investing $100 million into GammaDelta Therapeutics’ research and development funding. This will help accelerate GammaDelta Therapeutics’ growth and progress in the field of life sciences.
White City’s status as an emerging cluster for technology and innovation was confirmed by the NLA Knowledge Capital Report, which highlighted the positive effect that Imperial College’s White City Campus, with its new Molecular Sciences Research Hub, has had on scientific innovation and the pioneering ethos of the area. It described White City as ‘one of the main life science and tech districts,’ praising the interplay between its scientific research and its forward-looking companies.